Cidara Thera (CDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169,827 | -22,931 | -33,584 | -42,467 | -72,111 |
| Depreciation Amortization | 417 | 195 | 143 | -1,227 | 1,055 |
| Accounts receivable | 14,275 | -10,413 | -477 | 5,819 | -11,165 |
| Other Working Capital | -13,933 | -3,920 | 454 | 14,436 | 12,539 |
| Other Operating Activity | -7,465 | 14,637 | 4,991 | -1,793 | 15,271 |
| Operating Cash Flow | $-176,533 | $-22,432 | $-28,473 | $-25,232 | $-54,411 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -129 | -505 | -118 | -41 | -186 |
| Investing Cash Flow | $-129 | $-505 | $-118 | $-41 | $-186 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -2,593 | -4,444 | -2,963 |
| Common Stock Issued | 46 | 8,728 | 1,642 | 12,489 | 11,055 |
| Other Financing Activity | 337,015 | 17,256 | 0 | 36,552 | 29,186 |
| Financing Cash Flow | $337,061 | $25,984 | $-951 | $44,597 | $37,278 |
| Beginning Cash Position | 35,778 | 32,731 | 62,273 | 42,949 | 60,268 |
| End Cash Position | 196,177 | 35,778 | 32,731 | 62,273 | 42,949 |
| Net Cash Flow | $160,399 | $3,047 | $-29,542 | $19,324 | $-17,319 |
| Free Cash Flow | |||||
| Operating Cash Flow | -176,533 | -22,432 | -28,473 | -25,232 | -54,411 |
| Capital Expenditure | -129 | -505 | -118 | -41 | -186 |
| Free Cash Flow | -176,662 | -22,937 | -28,591 | -25,273 | -54,597 |